Skip to main content
. 2020 Jul 14;15:84. doi: 10.1186/s13000-020-01001-2

Fig. 2.

Fig. 2

IGV view of PMS2 and MSH6 mutations in patient 1. a IGV view of PMS2 R134* mutation in tumour and normal tissue. Variant allelic frequency (VAF) (green) was 50% in both samples. b IGV view of MSH6 c.3261dupC mutation in tumour and normal tissue. VAF was 36% in tumour sample